Atrial fibrillation (AF), a type of heart arrhythmia, is a heart condition wherein the heartbeat too fast, too slow, or irregular. According to a study in 2013, about 33.5 million people had arrhythmia worldwide. As per the estimation by Centers for Disease Control and Prevention (CDC), in 2015, about 2.7-6.1 million people had AF in the US. This condition is mostly seen among the older population (aged 60 and above). It occurs because of the malfunctioning in the electrical system of the heart, which leads to sudden cardiac arrest or heart failure.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Cost analysis of CRT-D device implantation

PART 06: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 07: Geographical segmentation

CRT-D market in Americas

CRT-D market in EMEA

CRT-D market in APAC

PART 08: Market drivers

Increased incidence of cardiac disorders

Increasing regulatory approvals

Clinical considerations

Increased public awareness

PART 09: Impact of drivers

PART 10: Market challenges

High cost

Popularity of alternative devices

Complications associated with CRT-D devices

PART 11: Impact of drivers and challenges

PART 12: Market trends

Increased use of MRI in clinical applications

Focus on R&D

Growing popularity of robotic-assistance surgery

PART 13: Vendor landscape

Competitive scenario

Market share analysis

Boston Scientific

LivaNova

Medtronic

St. Jude Medical

Other prominent vendors

PART 14: Appendix

List of abbreviations

PART 15: Explore Technavio